Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive enalapril and metoprolol in Duchenne muscular dystrophy
2009-009871-36Phase 3Completed
- Sponsor
- Friedrich-Alexander University Erlangen-Nuremberg
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of enalapril and metoprolol in Duchenne muscular dystrophy (DMD) (2 arms), sponsored by Friedrich-Alexander University Erlangen-Nuremberg. Primary endpoint: Time to left ventricular dysfunction. Started Aug 2009; status: completed.
02
Drugs
enalaprilmetoprolol
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2009-009871-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009871-36.